spacer
home > pmps > Winter 2012
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2012
   
Text
PDF
bullet
Manufacturing
New Manufacturing Challenges

Changing Lanes

New products mean new manufacturing systems, and as more complex products are created, drug production will have to adapt to the innovations coming from the development laboratories. Matthew Chandler at Sagentia Ltd shows manufacturers the way ahead.
 
view
download pdf
Prefilled Syringes: Filling Systems

The Future of Processing


Several market drivers are steering the prefilled syringe industry into new territory, requiring producers to step up their filling and closure systems, as Klaus Ullherr at Robert Bosch GmbH explains.
 
view
download pdf
Manufacturing Environment

Taking Care of Air


Air quality, humidity and temperature need to be monitored closely to ensure a stable manufacturing environment. Chris Hansford at Hansford Sensors presents guiding principles and technologies for maintaining air within required specifications.
 
view
download pdf
Prefilled Syringes: Quality by Design

Designed, Sealed and Delivered


A quality by design approach can render a syringe manufacturing facility that truly lives up to its potential and ensures a superior return on investment through an optimised plant structure, as Kay Schmidt at Catalent Pharma Solutions shows.
 
view
download pdf
Quality Control

Total Recall

In most cases, product recalls are disastrous, so manufacturers should pull out all stops to eliminate the possibility. This process can be assisted by suitable in-line testing and checks, as Todd Blonshine at Mustard Tree Instruments explains.
 
view
download pdf
bullet
Cool Chain, Cargo & Logistics
Clinical Trial Logistics: IT Systems

Chain Control

The march of technology will enhance management of the R&D supply chain and enable a clearer picture of product movement through superior IT solutions, as Dirk Machert and Jens Mattuschka at PAREXEL International present.
 
view
download pdf
The End of the Line

Is Bigger Better?

A packaging solution needs to be the best, rather than just the biggest, points out Richard Harrop.
 
view
download pdf
Spotlight: Cool Chain Association

The Ultimate Aim

The current initiatives of the Cool Chain Association promise to bring safer products into the supply chain and reduce the potential for waste.
 
view
download pdf
Air Cargo

Jet Set


How difficult is it to transport drugs by air? Christopher Dehio at Lufthansa Cargo AG explains why this method has a history of danger, and picks out the points in the process where temperaturesensitive cargo is most at risk.
 
view
download pdf
Transport Media

A Safe Platform

Jim Hardisty at Goplasticpallets.com
discusses physical risk in the logistics environment, and how devices such as pallets should be chosen carefully to ensure the safety of transport personnel.
 
view
download pdf
bullet
Drug Delivery 
Prefilled Syringes: Device Design

Style and Substance

To ensure patient safety and adherence, as well as create brand value, the design of a prefi lled syringe must be user-focused, and should encompass several guiding principles as part of the design concept, as Dan Formosa at Smart Design points out.

 
view
download pdf
bullet
Packaging, Packing & Anti-Counterfeiting
Global Packaging Strategies

Location, Location, Location


Streamlining the supply chain is the obvious option for companies looking to trim the fat from their distribution budget. But as Daniel Nott at Honeywell points out, they should also consider packaging technology itself, which can now provide protection for truly international conditions.
 
view
download pdf
Patient Information Leaflets

On the Same Page

Neil Gleghorn at Kallik highlights how patient information leafl ets are undergoing a transformation, and points to new EU readability guidelines that will require packagers to take a more proactive approach to keeping end-users informed.
 
view
download pdf
Primary Packaging

The Extractable Question

Michael Creese at Smithers Rapra
reviews the current trends in extractables and leachables testing, and makes several points of comparison between approaches in the pharmaceutical, food and medical device industries.
 
view
download pdf
Traceability: 21 CFR Part 11

Timed to Perfection

Electronic packaging systems that track products effectively are now a central element in the supply chain. Rob Dinsmore at SolutionsPT introduces the concept of ‘availability’, which can be incorporated into tracking systems in the form of hardware and software to eliminate costly errors.
 
view
download pdf
Radio-Frequency Identification

Riding the New Wave

As new technology and handheld devices continue their rise to dominance, Randy Stigall at UPM identifies the ways in which tracking pharmaceutical products can be made easier by buying into these new solutions, including near fi eld communication.
 
view
download pdf
bullet
Formulations, Ingredients and Excipients
API Manufacturing

Novel Dispensation

Howard Biddle at 42 Technology discusses the need for effective API dispensation for oral dosage, and shows how sticky web technology provides a simple yet precise option that is starting to be commercialised on a wider scale.
 
view
download pdf
   
spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August, and November

News and Press Releases

New Technologies for HPAPI Manufacturing and Containment

SMI Reports: With new technologies becoming available for the pharmaceutical industry, the HPAPI market is utilising these new innovations to simplify manufacturing processes reducing powder exposure and allowing a semi-continuous production. At this year's HPAPI USA Conference emerging manufacturing technologies will be one of the key points to be discussed along with containment issues, disaster management, Oncology Antibody-Drug Conjugates (ADCs) and staff training procedures.
More info >>

White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>

Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement